Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$4.05 - $5.43 $121 - $162
30 New
30 $0
Q2 2023

Aug 14, 2023

SELL
$3.72 - $4.79 $372 - $479
-100 Reduced 6.82%
1,367 $5,000
Q1 2023

May 15, 2023

BUY
$3.95 - $5.63 $395 - $563
100 Added 7.32%
1,467 $6,000
Q4 2022

Feb 21, 2023

SELL
$3.02 - $5.37 $36,179 - $64,332
-11,980 Reduced 89.76%
1,367 $7,000
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $18,810 - $27,365
6,291 Added 89.16%
13,347 $41,000
Q2 2022

Aug 04, 2022

BUY
$2.67 - $4.77 $13,854 - $24,751
5,189 Added 277.93%
7,056 $27,000
Q1 2022

May 09, 2022

BUY
$2.62 - $4.45 $3,529 - $5,994
1,347 Added 259.04%
1,867 $7,000
Q4 2021

Feb 03, 2022

SELL
$4.05 - $5.37 $729 - $966
-180 Reduced 25.71%
520 $2,000
Q3 2021

Nov 15, 2021

BUY
$3.89 - $5.48 $389 - $548
100 Added 16.67%
700 $3,000
Q2 2021

Aug 13, 2021

BUY
$3.61 - $5.45 $361 - $545
100 Added 20.0%
600 $3,000
Q1 2021

May 14, 2021

BUY
$3.14 - $6.14 $1,570 - $3,070
500 New
500 $2,000
Q4 2019

Feb 13, 2020

SELL
$1.14 - $1.49 $113 - $149
-100 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$1.04 - $1.44 $104 - $144
100 New
100 $0
Q2 2018

Aug 10, 2018

SELL
$1.59 - $2.38 $4,770 - $7,140
-3,000 Closed
0 $0
Q2 2017

Aug 10, 2017

BUY
N/A
3,000
3,000 $4,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.